Insider filing · ROIV
Jennifer Humes
Chief Accounting Officer
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 75 filings in 24 months
ticker →
Jennifer Humes sold $384K of Roivant Sciences (ROIV)
Executed Apr 8, disclosed Apr 10, 2 days later.
Value, as filed
$384K
13,538 sh × $28.37
Executed
Apr 8
the trade date, as filed
Disclosed
Apr 10
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JHJennifer Humes (Chief Accounting Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $384K of ROIV (13,538 sh × $28.37, as filed), executed Apr 8.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→